Imperial College London

Professor Jamie Murphy BChir PhD FRCS FASCRS - Consultant Colorectal Surgeon

Faculty of MedicineDepartment of Surgery & Cancer

Visiting Professor
 
 
 
//

Contact

 

jamie.murphy

 
 
//

Location

 

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Summary

Jamie Murphy completed his medical school training at the University of St. Andrews, Harvard University and St. John’s College, Cambridge. After qualification he undertook his Higher General Surgical Training at the Royal London Hospital and was awarded a PhD in Colorectal Molecular Oncology.

Following this training Jamie embarked upon three Colorectal Surgery fellowships at: St. Mark’s Hospital for specialist training in total pelvic exenteration & sacrectomy for locally advanced / recurrent rectal cancer; Basingstoke Peritoneal Malignancy Institute for specialist training in the use of heated intraperitoneal chemotherapy (HIPEC) for recurrent abdominal cancers; and, the Mayo Clinic in the USA for training in advanced minimally invasive surgery and the use of intraoperative radiotherapy to treat pelvic cancers that are unresectable. Following this sub-specialty training, Jamie was appointed as Assistant Professor of Surgery at Mayo Clinic prior to his return to London as a Consultant Colorectal Surgeon at Imperial College Healthcare NHS Trust, London.

Jamie’s specialist clinical and academic interests centre upon the treatment of bowel cancers that require advanced therapies due to their extent or complexity. As such, he has been responsible for the establishment of an advanced / recurrent pelvic cancer service at Imperial College Healthcare NHS Trust. Jamie undertakes surgery for cancers invading the pelvic organs or pelvic bones utilising intraoperative radiotherapy to increase survival rates for patients with these conditions. Jamie has established a trial assessing the use of high intensity focused ultrasound (HIFU) as a therapy for bowel cancer patients who have tumours that cannot be treated by conventional means. In addition, Jamie has established a heated intraperitoneal chemotherapy (HIPEC) service for recurrent bowel cancer and is investigating the use of Pressurised Intraperitoneal Aerosolised Chemotherapy (PIPAC) for patients who are not suitable for cytoreductive surgery and HIPEC.

Jamie has contributed to numerous surgical textbooks and published extensively in surgical journals. In addition, he has lectured worldwide on the subjects of advanced minimally invasive surgery and complex cancer, particularly in the USA where he has served as a faculty member for many of the American national surgical conferences. Jamie is the President Elect of the International Society for Digestive Surgery, a Fellow of the Royal Society of Medicine (RSM), a Fellow of the American Society of Colon and Rectal Surgeons (ASCRS) and he is also a member of the Society for American Gastrointestinal and Endoscopic Surgeons (SAGES).

Patients who wish to arrange an appointment or a second opinion to discuss one of the above services should seek a referral from their General Practitioner or Oncologist, which can be sent to jamie.murphy2 @ nhs.net, or faxed to 0203 311 1757. Alternatively private consultations can be arranged by contacting cclappointments @ ccf.org or by telephoning 020 3423 7500

Publications

Journals

Challoner BR, Woolston A, Lau D, et al., 2024, Genetic and immune landscape evolution in MMR-deficient colorectal cancer., J Pathol, Vol:262, Pages:226-239

Orlando A, Thomas G, Murphy J, et al., 2024, A systematic review and a meta-analysis on the incidence of obstetric anal sphincter injuries during vaginal delivery., Colorectal Dis, Vol:26, Pages:227-242

Nazarian S, Gkouzionis I, Murphy J, et al., 2024, Real-time classification of tumour and non-tumour tissue in colorectal cancer using diffuse reflectance spectroscopy and neural networks to aid margin assessment, International Journal of Surgery, ISSN:1743-9159

Kyle P, Perry K, Moutadjer A, et al., 2023, UK trial of pressurised intraperitoneal aerosolised chemotherapy (PIPAC) with oxaliplatin for colorectal cancer peritoneal metastases (NCT03868228), Pleura and Peritoneum, ISSN:2364-7671

Murphy J, Donato-Brown D, Efeotor O, et al., 2023, A prospective case series assessing the Imperial College London intraoperative radiotherapy protocol for advanced rectal cancer: an IDEAL phase 2a study, Colorectal Disease, ISSN:1462-8910

More Publications